Pamela Garzone - 19 Apr 2023 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
Director
Signature
/s/ Pamela Garzone by Colin Sandercock, attorney-in-fact
Issuer symbol
CUE
Transactions as of
19 Apr 2023
Net transactions value
$0
Form type
3
Filing time
25 Apr 2023, 16:11:00 UTC
Next filing
04 Jan 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney